SUPN Financials
Supernus Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$43.74
Market Cap
$2.53B
P/E Ratio
32.6
EPS
$1.34
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$661.82M
Gross Profit
-
Operating Income
-
Net Income
$73.86M
EPS (Diluted)
$1.32
Balance Sheet Highlights
Total Assets
$1.37B
Total Liabilities
$332.34M
Shareholders Equity
-
Cash & Equivalents
$69.33M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$171.95M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Net Margin
-3.7%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is SUPN revenue?
SUPN's most recent quarterly revenue was $661.82M. Annual revenue can be calculated by summing the four most recent quarters.
Is SUPN profitable?
SUPN reported a profit of $73.86M in the most recent quarter. The net profit margin is -3.7%.
What is SUPN market cap?
SUPN has a market capitalization of $2.53B, making it a mid-cap stock.
Does SUPN have debt?
View SUPN's balance sheet for debt information.
What is SUPN cash flow?
Cash flow data is available in the full financial statements.